Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 27, 2020

Primary Completion Date

June 13, 2020

Study Completion Date

June 13, 2020

Conditions
SARS-CoV Infection
Interventions
DRUG

Losartan

Standard of care plus the starting dose of losartan 12.5mg (investigator has option to increase dose on days 2-10 based on tolerance of SBP) of losartan taken twice daily for up to 10 days. Upon the treating clinician's discretion, losartan may be continued beyond 10 days for non-COVID-19 indications.

Trial Locations (3)

91911

Sharp Chula Vista Medical Center, San Diego

91942

Sharp Grossmont Hospital, La Mesa

92123

Sharp Memorial Hospital, San Diego

All Listed Sponsors
lead

Sharp HealthCare

OTHER